Sector revisions Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:05 2025-06-18 EDT			5-day change	1st Jan Change
94.97 ^CHF	-0.63%		-2.09%	+7.07%

06-17	Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May	MT
06-17	Trump Administration to Consider Pharma Advertising Crackdown	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	NOVARTIS AG							19
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							23
	NOVO NORDISK A/S							22
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	ASTRAZENECA PLC							20
	MERCK & CO., INC.							24
	AMGEN INC.							28
	PFIZER, INC.							23
	GILEAD SCIENCES, INC.							26
	SANOFI							23
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							22
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	GSK PLC							19
	JIANGSU HENGRUI MEDICINE CO., LTD.							16
	HALEON PLC							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							17
	Average							22
	Weighted average by Cap.							23